Q1 2017 Holdings
Filed 2017-05-15 | 9 holdings | $93.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Selecta Biosciences, Inc.(SELBUSD) | Common Stock | 816212104 | $27.6K | 1,924,151 | 29.5% |
| Pulmatrix Inc. | Common Stock | 74584P103 | $12.6K | 3,607,996 | 13.5% |
| Genocea Biosciences, Inc. | Common Stock | 372427104 | $12.0K | 1,968,606 | 12.8% |
| Fate Therapeutics, Inc.(FATE) | Common Stock | 31189P102 | $11.3K | 2,473,186 | 12.0% |
| T2 Biosystems, Inc. | Common Stock | 89853L104 | $9.9K | 1,875,524 | 10.6% |
| Trevena, Inc. | Common Stock | 89532E109 | $7.5K | 2,053,540 | 8.1% |
| Atyr Pharma Inc.(LIFEUSD) | Common Stock | 002120103 | $6.4K | 1,827,992 | 6.8% |
| Ocular Therapeutix, Inc.(OCUL) | Common Stock | 67576A100 | $3.6K | 383,141 | 3.8% |
| Cerulean Pharma Inc | Common Stock | 15708Q105 | $2.7K | 3,287,529 | 2.9% |